NRC Health Total Assets
NRC Health (NRC) had Total Assets of $136.15 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $136.15M.
- 2026-03-31: Assets $134.56M.
- 2025-12-31: Assets $134.88M.
- 2025-09-30: Assets $135.72M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $136.15M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $134.56M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $134.88M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $135.72M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $141.39M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $135.18M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $132.54M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $131.80M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $119.10M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $120.91M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $122.44M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $120.14M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $133.63M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $134.31M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $130.46M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $134.98M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $136.23M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $153.15M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $157.54M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $156.19M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $151.85M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $146.88M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $133.42M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $127.25M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $116.78M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $115.86M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $110.69M 10-K · filed 2022-03-04 | |
| 2019-09-30 | $107.65M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $104.28M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $104.57M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $108.03M 10-K · filed 2021-03-05 | |
| 2018-09-30 | $108.72M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $102.89M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $130.98M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $127.32M 10-K · filed 2020-03-06 | |
| 2017-09-30 | $128.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $124.58M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $126.06M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $120.62M 10-K · filed 2019-03-08 | |
| 2016-09-30 | $119.30M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $116.50M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $118.37M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $128.05M 10-K · filed 2018-03-14 | $129.10M 10-K · filed 2016-03-04 |
| 2015-09-30 | $129.48M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $131.05M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $128.45M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $129.51M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $127.06M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $121.87M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $116.28M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $111.09M 10-K · filed 2016-03-04 | $111.00M 10-K · filed 2014-03-04 |
| 2013-09-30 | $109.91M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $104.90M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $103.50M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $100.05M 10-K · filed 2015-03-04 | |
| 2012-09-30 | $109.43M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $105.59M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $103.38M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $100.68M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $100.95M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $100.30M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $95.77M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |